Boston, MA 04/04/2014 (wallstreetpr) – Amyris Inc (NASDAQ:AMRS) is engaged in providing of renewable compounds with wide-range applications. The company’s products provide platform for creating of specialty chemicals and fuel as alternative to petroleum products. It is focused currently on creating a range of industrial synthetic products for use in markets such as flavors, fragrance, lubricants, cosmetics and transportation fuels. The long hydrocarbon chain compounds are developed through conversion of plant sugar into long-chain molecules.
According to Amyris, its products are comparable with or better than those available from conventional sources.
A unique business
This being kind of a unique business, Amyris Inc (NASDAQ:AMRS) is stepping out to collaborate with strategic partners. These collaborative activities are expected to enable the company obtain funds for the financing of its research and development projects and also getting its products to the market quickly and easily.
Thus, the company can be seen singing engineering collaboration in order to expand its research activities and diversify products creation. The company is also reaching out to partners which can offer the financial support needed to boost operations. Yet again, Amyris Inc (NASDAQ:AMRS) is networking with strategic partners to ensure that its products are not only made available to those who need them, but that the use of the products also leads to more diversified applications beyond the commercial realm.
For example, Amyris just announced its engineering collaboration with BASF SE. the collaboration will allow it to use the BASF’s strain technology in developing a micro-organism which capability to produce BASF-target molecule. The success of the initial program based on this agreement will lead to further tie-up in research and development opportunities between the companies.
Amyris Inc (NASDAQ:AMRS) also announced collaboration with Kuraray which involves the extension and expansion of the development of polymers through Biofene. The parties agreed to extend their previous research and development collaboration by two more years. The latest agreement also expands the usage of Kuraray products containing Biofene.
Thus, Kuraray has agreed to make an undisclosed cash payment to Amyris over the next two years. Kuraray will also acquire common stock shares of Amyris Inc (NASDAQ:AMRS) worth $4 million, later this month.
Tapping opportunities
It is encouraging to see that Amyris Inc (NASDAQ:AMRS)’s technology is beginning to attract big investors and high-profile partners. These collaborative efforts should help the company to quickly and easily tap market and research opportunities.
